Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

691 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRCAness as a prognostic indicator in patients with early breast cancer.
Liu L, Matsunaga Y, Tsurutani J, Akashi-Tanaka S, Masuda H, Ide Y, Hashimoto R, Inuzuka M, Watanabe C, Taruno K, Sawada T, Okuyama H, Ata A, Kuwayama T, Nakayama S, Tonouchi Y, Nakamura S. Liu L, et al. Among authors: matsunaga y. Sci Rep. 2020 Dec 3;10(1):21173. doi: 10.1038/s41598-020-78016-8. Sci Rep. 2020. PMID: 33273622 Free PMC article.
Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy.
Masuda H, Harano K, Miura S, Wang Y, Hirota Y, Harada O, Jolly MK, Matsunaga Y, Lim B, Wood AL, Parinyanitikul N, Jin Lee H, Gong G, George JT, Levine H, Lee J, Wang X, Lucci A, Rao A, Schweitzer BL, Lawrence OR, Seitz RS, Morris SW, Hout DR, Nakamura S, Krishnamurthy S, Ueno NT. Masuda H, et al. Among authors: matsunaga y. JCO Precis Oncol. 2022 Mar;6:e2000368. doi: 10.1200/PO.20.00368. JCO Precis Oncol. 2022. PMID: 35294223 Free PMC article.
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
Fujii T, Masuda H, Cheng YC, Yang F, Sahin AA, Naoi Y, Matsunaga Y, Raghavendra A, Sinha AK, Fernandez JRE, James A, Yamagishi K, Matsushima T, Schuetz R, Tripathy D, Tada S, Jackson RS, Noguchi S, Nakamura S, Acoba JD, Ueno NT. Fujii T, et al. Among authors: matsunaga y. Breast Cancer Res Treat. 2021 Sep;189(2):455-461. doi: 10.1007/s10549-021-06276-7. Epub 2021 Jun 15. Breast Cancer Res Treat. 2021. PMID: 34131830
Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women.
Sawada T, Akashi S, Nakamura S, Kuwayama T, Enokido K, Yoshida M, Hashimoto R, Ide T, Masuda H, Taruno K, Oyama H, Takamaru T, Kanada Y, Ikeda M, Kosugi N, Sato H, Nakayama S, Ata A, Tonouchi Y, Sakai H, Matsunaga Y, Matsutani A. Sawada T, et al. Among authors: matsunaga y. Breast Cancer. 2017 Sep;24(5):708-713. doi: 10.1007/s12282-017-0763-2. Epub 2017 Feb 25. Breast Cancer. 2017. PMID: 28238177
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y, Ide Y, Inuzuka M, Tazawa S, Kanada Y, Matsunaga Y, Kuwayama T, Sawada T, Akashi-Tanaka S, Nakamura S. Liu Y, et al. Among authors: matsunaga y. Mol Genet Genomic Med. 2019 Mar;7(3):e493. doi: 10.1002/mgg3.493. Epub 2019 Jan 16. Mol Genet Genomic Med. 2019. PMID: 30652428 Free PMC article.
691 results